Levothyroxine Recall 2026 vs. Past Recalls: What Makes This One Different?

Levothyroxine Recall
Major Pharmaceuticals announced a nationwide Class II recall of certain levothyroxine sodium tablets in July 2026 after routine stability testing showed that some tablets were subpotent, meaning they contained less... Read More

I WANT TO LEARN MORE!







    By submitting your information, you agree to our website Terms and Conditions and our Privacy Policy. You'll also receive our email newsletters, account updates and special offers, sent to you by Patients-Medical.